Abstract
Background and aims: Evidence suggests patients with inflammatory bowel disease [IBD] receiving TNF antagonists have attenuated response to vaccination against COVID-19. We sought to determine the impact of IBD and of various medications for treatment of IBD on antibody responses to vaccination against COVID-19.
Methods: Patients with IBD [n = 270] and healthy controls [HC, n = 116] were recruited prospectively, and quantitative antibody responses were assessed following COVID-19 vaccination. The impact of IBD and of medications for treatment of IBD on vaccine response rates was investigated.
Results: Of HC, 100% seroconverted following complete vaccination with two vaccine doses; 2% of patients with IBD failed to seroconvert. Median anti-spike protein [SP] immunoglobulin [Ig]G levels following complete vaccination in our IBD cohort was significantly lower than among HC [2613 AU/mL versus 6871 AU/mL, p ≤0.001]. A diagnosis of IBD was independently associated with lower anti-SP IgG levels [β coefficient -0.2, p = 0.001]. Use of mRNA vaccines was independently associated with higher anti-SP IgG levels [β coefficient 0.25, p ≤0.001]. Patients with IBD receiving TNF inhibitors had significantly lower anti-SP IgG levels [2445 AU/mL] than IBD patients not receiving TNF inhibitors [3868 AU/mL, p ≤0.001]. Patients with IBD not receiving TNF inhibitors still showed attenuated responses compared with HC [3868 AU/mL versus 8747 AU/mL, p = 0.001].
Conclusions: Patients with IBD have attenuated serological responses to SARS-CoV-2 vaccination. Use of anti-TNF therapy negatively affects anti-SP IgG levels further. Patients who do not seroconvert following vaccination are a particularly vulnerable cohort. Impaired responses to vaccination in our study highlight the importance of booster vaccination programmes for patients with IBD.
Keywords: COVID-19 vaccination; Inflammatory bowel disease; anti-tumour necrosis factor antagonists.
【저자키워드】 Inflammatory bowel disease, COVID-19 vaccination, anti-tumour necrosis factor antagonists., 【초록키워드】 COVID-19, Treatment, Necrosis, Vaccine, vaccination, therapy, mRNA vaccine, Antibody Response, Diagnosis, Protein, Cohort, Immunoglobulin, vaccine response, response, Patient, medication, inhibitor, Quantitative, SARS-CoV-2 vaccination, Anti-spike, IBD, booster vaccination, serological response, TNF, anti-TNF, healthy control, antagonists, seroconvert, significantly lower, bowel, Affect, Complete, vaccination against COVID-19, highlight, recruited, investigated, receiving, seroconverted, determine, Impaired, anti-SP IgG, response to vaccination, TNF antagonist, were assessed, 【제목키워드】 COVID-19, response, IBD, TNF, diminished, Result, Against,